COVID-19-associated diabetes mellitus differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
TayyabaAli (talk | contribs) |
TayyabaAli (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{TAM}} | {{CMG}}; {{AE}} {{TAM}} | ||
==Overview== | ==Overview== | ||
COVID-19-associated diabetes mellitus | COVID-19-associated diabetes mellitus diagnosis should be differentiated from other diseases manifesting with [[polyuria]], [[polydipsia]], and [[hyperglycemia]]. | ||
==Differentiating COVID-19-associated diabetes mellitus from other Diseases== | ==Differentiating COVID-19-associated diabetes mellitus from other Diseases== | ||
*COVID-19-associated diabetes mellitus | *COVID-19-associated diabetes mellitus diagnosis should be differentiated from other diseases manifesting with [[polyuria]], [[polydipsia]], and [[hyperglycemia]]. | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
! rowspan="2" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Disease}} | ! rowspan="2" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Disease}} |
Latest revision as of 06:41, 31 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]
Overview
COVID-19-associated diabetes mellitus diagnosis should be differentiated from other diseases manifesting with polyuria, polydipsia, and hyperglycemia.
Differentiating COVID-19-associated diabetes mellitus from other Diseases
- COVID-19-associated diabetes mellitus diagnosis should be differentiated from other diseases manifesting with polyuria, polydipsia, and hyperglycemia.
Disease | History and symptoms | Laboratory findings | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Polyuria | Polydipsia | Polyphagia | Weight loss | Weight gain | Serum glucose | Urinary Glucose | Urine PH | Serum Sodium | Urinary Glucose | 24 hrs cortisol level | C-peptide level | Serum glucagon | ||
Type 1 Diabetes mellitus[1] | + | + | + | + | - | ↑ | ↑ | Normal | Normal | N/↑ | Normal | ↓ | Normal | Auto antibodies present
(Anti GAD-65 and anti insulin anti bodies) |
Type 2 Diabetes mellitus[1] | + | + | + | + | - | ↑ | ↑ | Normal | Normal | ↑ | Normal | Normal | ↑ | Acanthosis nigricans |
Maturity onset diabetes of young[2] | + | + | + | - | + | ↑ | ↑ | Normal | Normal | ↑ | Normal | Normal | N | - |
Psychogenic polydipsia[3] | + | + | - | - | - | Normal | Normal | Normal | ↓ | Normal | Normal | Normal | Normal | - |
Diabetes insipidus[3] | + | + | - | - | - | Normal | Normal | Normal | ↑ | Normal | Normal | Normal | Normal | - |
Transient hyperglycemia[4] | - | - | - | - | - | ↑ | ↑ | Normal | Normal | ↑ | Normal | Normal | N/↑ | In hospitalized patients especially in ICU and CCU |
Steroid therapy[5] | + | - | - | - | + | ↑ | ↑ | Normal | Normal | ↑ | ↑ | N/↑ | N/↑ | Acanthosis nigricans, |
RTA 1[6] | - | - | - | + | - | Normal | Normal | ↑ | Normal | ↑ | Normal | Normal | Normal | Hypokalemia, nephrolithiasis |
Glucagonoma[7] | - | - | - | - | - | ↑ | Normal | Normal | Normal | - | Normal | Normal | ↑ | Necrolytic migratory erythema |
Cushing syndrome[8] | - | - | - | - | + | ↑ | - | Normal | ↓ | N/↑ | ↑ | Normal | Normal | Moon face, obesity, buffalo hump, easy bruisibility |
COVID-19-associated diabetes mellitus[9] | + | + | - | - | - | ↑ | - | - | ↓ | - | - | - | - | New onset diabetes in a patient infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[10] |
- To browse the differential diagnosis of COVID-19, Click here.
References
- ↑ 1.0 1.1 "Diabetes Overview - Symptoms, Causes, Treatment".
- ↑ "Monogenic Diabetes (Neonatal Diabetes Mellitus & MODY) | NIDDK".
- ↑ 3.0 3.1 "Thirst - excessive: MedlinePlus Medical Encyclopedia".
- ↑ Harp JB, Yancopoulos GD, Gromada J (2016). "Glucagon orchestrates stress-induced hyperglycaemia". Diabetes Obes Metab. 18 (7): 648–53. doi:10.1111/dom.12668. PMC 5084782. PMID 27027662.
- ↑ Tamez-Pérez HE, Quintanilla-Flores DL, Rodríguez-Gutiérrez R, González-González JG, Tamez-Peña AL (2015). "Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review". World J Diabetes. 6 (8): 1073–81. doi:10.4239/wjd.v6.i8.1073. PMC 4515447. PMID 26240704.
- ↑ "Distal renal tubular acidosis: MedlinePlus Medical Encyclopedia".
- ↑ "Glucagonoma: MedlinePlus Medical Encyclopedia".
- ↑ "Cushing Syndrome | Hypercortisolism | MedlinePlus".
- ↑ Chee YJ, Ng SJH, Yeoh E (2020). "Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus". Diabetes Res Clin Pract. 164: 108166. doi:10.1016/j.diabres.2020.108166. PMC 7194589 Check
|pmc=
value (help). PMID 32339533 Check|pmid=
value (help). - ↑ Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein S, Eckel RH; et al. (2020). "New-Onset Diabetes in Covid-19". N Engl J Med. doi:10.1056/NEJMc2018688. PMC 7304415 Check
|pmc=
value (help). PMID 32530585 Check|pmid=
value (help).